Compared with the participants of “NAFLD alone”, “overlapping FLD” patients had a higher percentage of DM, hypertension history, and hyperlipidemia history, higher levels of BMI, body fat, WC, glucose, HbA1C, triglyceride, AST, ALT, GGT, FLI, NFS, and uric acid, but a lower level of eGFR. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.